EULAR® 2024 Insights


 

EULAR® 2024 Insights: Implications of Newly Established Malignancy Screening Guidelines for Idiopathic Inflammatory Myopathies: A Multicentre, International Evaluation of Clinical and Economic Impact by the Myositis Audit and Research Collaborative Group

4 views
July 24, 2024
0 Comments
Login to view comments. Click here to Login